Kameyama Y, Hayashi T
Int J Exp Pathol. 1994; 75(4):295-304.
PMID: 7947231
PMC: 2002235.
Theofilopoulos A, Dixon F
Am J Pathol. 1982; 108(3):319-65.
PMID: 7051837
PMC: 1916035.
Nakao Y, Hattori T, Takatsuki K, Kuroda Y, Nakaji T, Fujiwara Y
Clin Exp Immunol. 1980; 42(1):10-9.
PMID: 7006872
PMC: 1537053.
Kitahara T, Okumura K, Semba A, Yamaura A, Makino H
J Neurol Neurosurg Psychiatry. 1982; 45(11):1048-52.
PMID: 6983566
PMC: 491644.
DOI: 10.1136/jnnp.45.11.1048.
Imai Y, Osawa T
Clin Exp Immunol. 1982; 49(3):572-8.
PMID: 6983402
PMC: 1536708.
Thymocytotoxic antibodies in patients with autoimmune hemolytic anemia, systemic lupus erythematosus and lymphoproliferative diseases.
Fagiolo E
Blut. 1982; 44(4):225-30.
PMID: 6979365
DOI: 10.1007/BF00319908.
Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
Kumagai S, Steinberg A, Green I
J Clin Invest. 1981; 67(3):605-14.
PMID: 6970750
PMC: 370608.
DOI: 10.1172/JCI110074.
Impaired antibody response against T-dependent antigens in rhino mice.
Takaoki M, Kawaji H
Immunology. 1980; 40(1):27-32.
PMID: 6968290
PMC: 1458494.
Regulation of the immune response in experimental models of autoimmune disorders: resistance of (NZB X NZW)F1 mice to tolerance induction in vivo.
Barzilay M, Moscovitch M, Slavin S
Clin Exp Immunol. 1983; 51(3):558-64.
PMID: 6851246
PMC: 1536798.
T cell abnormalities in NZB mice occur independently of autoantibody production.
Taurog J, Raveche E, Smathers P, Glimcher L, Huston D, Hansen C
J Exp Med. 1981; 153(2):221-34.
PMID: 6453918
PMC: 2186070.
DOI: 10.1084/jem.153.2.221.
Monoclonal IgM antibody exhibiting high-affinity binding and cryoglobulin properties.
Ballard D, Kranz D, Voss Jr E
Proc Natl Acad Sci U S A. 1983; 80(16):5071-4.
PMID: 6348779
PMC: 384190.
DOI: 10.1073/pnas.80.16.5071.
Tissue graft rejection in murine models of autoimmune disease.
Schultz J, Walker S, Beals T
Clin Exp Immunol. 1983; 51(2):325-32.
PMID: 6340872
PMC: 1536894.
Specific and non-specific suppressor cell activity in NZB mice.
Cooke A, Hutchings P, Nayak R
Immunology. 1980; 40(3):335-42.
PMID: 6159307
PMC: 1458064.
Immune complexes in human diseases: a review.
Theofilopoulos A, Dixon F
Am J Pathol. 1980; 100(2):529-94.
PMID: 6157327
PMC: 1903541.
Autoimmune disease and malignant lymphoma associated with host-versus-graft disease in mice.
Tateno M, Kondo N, Itoh T, Yoshiki T
Clin Exp Immunol. 1985; 62(3):535-44.
PMID: 4085149
PMC: 1577477.
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
Wofsy D, Seaman W
J Exp Med. 1985; 161(2):378-91.
PMID: 3919141
PMC: 2187572.
DOI: 10.1084/jem.161.2.378.
Establishment of monoclonal antibodies which possess the same characteristics as the naturally occurring thymocytotoxic autoantibodies (NTA).
Tani K, Sakamoto H, Katoh K, Matsunagai K, Yamada S, Okuda K
Rheumatol Int. 1986; 6(1):19-24.
PMID: 3491409
DOI: 10.1007/BF00270660.
The antiphosphorylcholine plaque-forming cell responses induced by the nematode Trichinella in BWF1 mice.
Ubeira F, Leiro J, Seoane R, Regueiro B
Med Microbiol Immunol. 1987; 176(3):143-50.
PMID: 3299017
DOI: 10.1007/BF00193895.
Effects of antigen and internal environment on anti-phosphorylcholine immune responses of autoimmune aged NZB/W F1 mice.
Seoane R, Faro J, Eiras A, Lareo I, Couceiro J, Regueiro B
Immunology. 1986; 58(2):329-34.
PMID: 2940174
PMC: 1452670.
Contrasuppression in autoimmunity.
Kelly C, Neilson E
Immunol Res. 1988; 7(1):56-66.
PMID: 2897411
DOI: 10.1007/BF02918154.
